1. Laue H, Friedrich M, Ruff J, Cook AM. Dissimilatory sulfite reductase (desulfoviridin) of the taurine-degrading, non-sulfate-reducing bacterium Bilophilawadsworthia RZATAU contains a fused DsrB-DsrD subunit. J Bacteriol. 2001; 183(5): 1727-1733. DOI: 10.1128/JB.183.5.1727-1733.2001. [
DOI:10.1128/JB.183.5.1727-1733.2001]
2. Baron EJ, Bennion R, Thompson J, Strong C, Summanen P, McTeague M, Finegold SM. A microbiological comparison between acute and complicated appendicitis. Clin Infect Dis. 1992; 14(1): 227-231. doi.org/10.1093/clinids/14.1.227 [
DOI:10.1093/clinids/14.1.227]
3. Baron EJ, Summanen P, Downes J, Roberts MC, Wexler H, Finegold SM. Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. J Gen Microbiol. 1989; 135(12): 3405-11. [
DOI:10.1099/00221287-135-12-3405]
4. Baron EJ, Curren M, Henderson G, Jousimies-Somer H, Lee K, Lechowitz K, Strong CA, et al. Bilophila wadsworthia isolates from clinical specimens. J Clin Microbiol. 1992; 30:1882-1884. [
DOI:10.1128/JCM.30.7.1882-1884.1992]
5. Summanen PH, Jousimies-Somer H, Manley S, Goldstein EJC, Finegold SM. Bilophila wadsworthia isolates from clinical specimens. Clin Infect Dis. 1995; 20 (Suppl 2): S210-1 [
DOI:10.1093/clinids/20.Supplement_2.S210]
6. Finegold S, Summanen P, Gerardo SH, Baron E. Clinical importance of Bilophila wadsworthia. Eur J Clin Microbiol Infect Dis. 1992; 11(11): 1058-63. [
DOI:10.1007/BF01967799]
7. Laue H, Smits TH, Schumacher UK, Claros MC, Hartemink R, Cook AM. Identification of Bilophila wadsworthia by specific PCR which targets the taurine: pyruvate aminotransferase gene. FEMS Microbiol Lett. 2006; 261(1): 74-79. [
DOI:10.1111/j.1574-6968.2006.00335.x]
8. Urbán E, Hortobágyi A, Szentpáli K, Nagy E. Two intriguing Bilophila wadsworthia cases from Hungary. J Med Microbiol. 2004; 53(11): 1167-1169. [
DOI:10.1099/jmm.0.45678-0]
9. McOrist AL, Warhurst M, McOrist S, Bird AR. Colonic infection by Bilophila wadsworthia in pigs. J Clin Microbiol. 2001; 39(4): 1577-9. [
DOI:10.1128/JCM.39.4.1577-1579.2001]
10. Da Silva SM, Venceslau SS, Fernandes CL, Valente FM, Pereira IA. Hydrogen as an energy source for the human pathogen Bilophila wadsworthia. Antonie Van Leeuwenhoek. 2008; 93(4): 381-390. [
DOI:10.1007/s10482-007-9215-x]
11. Sapico FL, Reeves D, Wexler HM, Duncan J, Wilson KH. and Finegold SM. Preliminary study using species-specific oligonucleotide probe for rRNA of Bilophila wadsworthia. J Clin Microbiol. 1994; 32 (10): 2510-2513. [
DOI:10.1128/JCM.32.10.2510-2513.1994]
12. Laue H, Denger K. and Cook AM. Taurine reduction in anaerobic respiration of Bilophila wadsworthia. Appl Environm Microbiol. 1997; 63(5): 2016-2021. [
DOI:10.1128/AEM.63.5.2016-2021.1997]
13. Bennion RS, Baron EJ, Thompson JE Jr, Downes J, Summanen P, Talan DA, Finegold SM. The bacteriology of gangrenous and perforated appendicitis-revisited. Annual Surgery. 1990; 211(2): 165-171. [
DOI:10.1097/00000658-199002000-00008]
14. Bennion, RS, Thompson JE, Baron EJ, Finegold SM. Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology. Clin Ther. 1990; 12 (Suppl C): 31-44.
15. Gerardo SH, Marina M, Citron DM, Claros MC, Hudspeth MK, Goldstein EJC. Bilophila wadsworthia clinical isolates compared by polymerase chain reaction fingerprinting. Clin Infect Dis. 1997; 25(Suppl 2): S291-4. [
DOI:10.1086/516229]
16. Finegold SM, Bennion RS, Thompson JE, Wexler HM, Baron EJ. Gangrenous and/or perforated appendix: clinical outcome and in vitro susceptibility testing. Hospital Practice. 1990; 25(S4): 3-12. [
DOI:10.1080/21548331.1990.11704110]
17. Schumacher UK, Eiring P, Häcker FM. Incidence of Bilophila wadsworthia in appendiceal, peritoneal and fecal samples from children. Clin Microbiol Infect. 1997; 3(1): 134-136. [
DOI:10.1111/j.1469-0691.1997.tb00264.x]
18. Feng Z, Long W,Hao B, Ding D, MaX,Zhao L, Pang X. A human stool-derived Bilophilawadsworthia strain caused systemic inflammation in specific-pathogen-free mice. Gut Pathology. 2017; 9: 59. DOI 10.1186/s13099-017-0208-7. [
DOI:10.1186/s13099-017-0208-7]